130 related articles for article (PubMed ID: 22888427)
1. Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Kikkawa S; Sogawa K; Satoh M; Umemura H; Kodera Y; Matsushita K; Tomonaga T; Miyazaki M; Yokosuka O; Nomura F
Int J Proteomics; 2012; 2012():108609. PubMed ID: 22888427
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.
Loosen SH; Breuer A; Tacke F; Kather JN; Gorgulho J; Alizai PH; Bednarsch J; Roeth AA; Lurje G; Schmitz SM; Brozat JF; Paffenholz P; Vucur M; Ritz T; Koch A; Trautwein C; Ulmer TF; Roderburg C; Longerich T; Neumann UP; Luedde T
JHEP Rep; 2020 Apr; 2(2):100080. PubMed ID: 32140677
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.
Sandanayake NS; Camuzeaux S; Sinclair J; Blyuss O; Andreola F; Chapman MH; Webster GJ; Smith RC; Timms JF; Pereira SP
BMC Clin Pathol; 2014 Feb; 14(1):7. PubMed ID: 24495412
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
Christensen TD; Maag E; Larsen O; Feltoft CL; Nielsen KR; Jensen LH; Leerhøy B; Hansen CP; Chen IM; Nielsen DL; Johansen JS
JHEP Rep; 2023 Mar; 5(3):100648. PubMed ID: 36699667
[TBL] [Abstract][Full Text] [Related]
5. A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.
Sandanayake NS; Sinclair J; Andreola F; Chapman MH; Xue A; Webster GJ; Clarkson A; Gill A; Norton ID; Smith RC; Timms JF; Pereira SP
Br J Cancer; 2011 Oct; 105(9):1370-8. PubMed ID: 21970875
[TBL] [Abstract][Full Text] [Related]
6. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.
Sugimoto M; Takagi T; Konno N; Suzuki R; Asama H; Watanabe K; Nakamura J; Waragai Y; Kikuchi H; Takasumi M; Sato Y; Hikichi T; Ohira H
Sci Rep; 2017 Aug; 7(1):9198. PubMed ID: 28835660
[TBL] [Abstract][Full Text] [Related]
8. Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer.
Loosen SH; Halpaap J; Labuhn S; Bednarsch J; Alizai PH; Roeth AA; Lang SA; Vucur M; Kather JN; Knoefel WT; Ulmer TF; Neumann UP; Roderburg C; Luedde T
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139589
[TBL] [Abstract][Full Text] [Related]
9. Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer.
Roderburg C; Labuhn S; Bednarsch J; Lang SA; Schneider AT; Hammerich L; Vucur M; Ulmer TF; Neumann UP; Luedde T; Loosen SH
Mediators Inflamm; 2022; 2022():6195004. PubMed ID: 36505756
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer.
Loosen SH; Ulmer TF; Labuhn S; Bednarsch J; Lang SA; Alizai PH; Schneider AT; Vucur M; Neumann UP; Luedde T; Roderburg C
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077611
[TBL] [Abstract][Full Text] [Related]
11. The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Xu J; Xu B; Tang C; Li X; Qin H; Wang W; Wang H; Wang Z; Li L; Li Z; Gao H; He K; Liu X
Dis Markers; 2017; 2017():3160426. PubMed ID: 28386154
[No Abstract] [Full Text] [Related]
12. The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer.
Sugimoto M; Abe K; Hayashi M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hashimoto M; Hikichi T; Nozawa Y; Ohira H
Sci Rep; 2018 Nov; 8(1):16997. PubMed ID: 30451962
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
[TBL] [Abstract][Full Text] [Related]
14. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
[TBL] [Abstract][Full Text] [Related]
15. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
[TBL] [Abstract][Full Text] [Related]
16. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
[TBL] [Abstract][Full Text] [Related]
17. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
18. Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis.
Cuenco J; Wehnert N; Blyuss O; Kazarian A; Whitwell HJ; Menon U; Dawnay A; Manns MP; Pereira SP; Timms JF
Oncotarget; 2018 Apr; 9(25):17430-17442. PubMed ID: 29707118
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry.
Lin CH; Su H; Hung CC; Lane HY; Shiea J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
